Skip to main content
INO
NASDAQ Life Sciences

Inovio Posts $49.2M Q3 Loss as First Commercial Launch of VOCERYQ Takes Shape

Tom Rudovsky · Reported by PR Newswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$1.46
Mkt Cap
$149.926M
52W Low
$0.563
52W High
$2.72
52W Position info
159% above low
Off High info
46% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

INO has more than doubled off its 52-week low of $0.563.

Summary

Inovio reported a Q3 net loss of $49.2 million, or $0.50 per share, but $26.9 million of that is a non-cash warrant remeasurement tied to share price, not operations. Operating expenses actually fell to $19.8 million from $21.2 million a year ago, with R&D down and SG&A up on launch preparation. Cash stood at $48.4 million at quarter-end; adding the $80.5 million November offering and $10.9 million in warrant proceeds, management now guides runway into late Q4 2027, past the VOCERYQ launch. The commercial timeline is the real story: VOCERYQ should be orderable roughly 60 days from the October 30 approval, with full field deployment in Q1 2027, and Syneos Health is handling field team recruitment. Watch the confirmatory study protocol submission to FDA by end of 2026 and the European conditional marketing authorization filing before year-end.

At the time of this announcement, INO was trading at $1.46 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $149.9M. The 52-week trading range was $0.56 to $2.72. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

INO - Latest Insights

INO
Nov 10, 2026, 4:01 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.47
Real-time Price: $1.41 info
Change: -$0.060 (-4%) info
Market Cap: $152.511M info
INO
Nov 09, 2026, 7:30 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.37
Real-time Price: $1.41 info
Change: +$0.040 (+3%) info
Market Cap: $152.511M info
INO
Nov 06, 2026, 4:30 PM EST
Filing Type: 424B5
Importance Score:
8
Price at Filing: $1.21
Real-time Price: $1.41 info
Change: +$0.200 (+17%) info
Market Cap: $152.511M info
INO
Nov 05, 2026, 11:19 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1.23
Real-time Price: $1.41 info
Change: +$0.1806 (+15%) info
Market Cap: $152.511M info
INO
Nov 05, 2026, 7:46 PM EST
Filing Type: FWP
Importance Score:
7
Price at Filing: $1.15
Real-time Price: $1.41 info
Change: +$0.2592 (+23%) info
Market Cap: $152.511M info